Latest market price
2.18
-0.07-3.11%
OverviewShort InterestFilings
MPTQT37Medical Properties Trust, Inc.·NYSE
2.18-3.11%
Analyst
Down 3.1% — RBC Capital downgraded to Underperform, price target $2.
High confidence
TA
Loading chart...
Signal & projected range
Analyst consensus risingHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
DHC-0.51%$7.74LTC+0.87%$45.14UHT+1.41%$38.79NHI+2.18%$68.50XRN+0.95%$30.66CHCT+1.07%$13.20SBRA-0.10%$19.72HR+3.41%$19.12
Snapshot
Index—P/E5.19EPS (ttm)0.42Insider Own2.82%Shs Outstand597.20MPerf Week-22.14%
Market Cap1.30BForward P/E—EPS next Y-0.01Insider Trans0.01%Shs Float490.07MPerf Month-33.33%
Enterprise Value9.96BPEG—EPS next Q0.00Short Float30.49%Perf Quarter-53.12%
Income249.00MP/S1.26EPS this Y—Short Ratio15.72Perf Half Y-56.14%
Sales1.03BP/B0.28EPS next Y—ROA1.73%Short Interest149.42MPerf YTD-56.40%
Book/sh7.74P/C2.17EPS next 5Y—ROE5.45%52W High6.47 -66.31%Perf Year-57.83%
Cash/sh1.00P/FCF5.74EPS past 3/5Y—ROIC4.07%52W Low2.03 7.39%Perf 3Y-57.75%
Dividend Est.0.36 (16.51%)EV/EBITDA7.37Sales past 3/5Y-14.28% -4.89%Gross Margin82.46%Volatility10.63% 5.81%Perf 5Y-89.23%
Dividend TTM0.36 (16.51%)EV/Sales9.66EPS Y/Y TTM—Oper. Margin55.11%ATR (14)0.18Perf 10Y-85.23%
Dividend Ex-DateSep 10, 2026Quick Ratio1.49Sales Y/Y TTM10.03%Profit Margin24.14%RSI (14)18.33Recom2.79
Dividend Gr. 3/5Y-34.23% -21.11%Current Ratio1.49EPS Q/Q361.54%SMA20-23.62%Beta1.54Target Price2.90
Payout82.82%Debt/Eq2.00Sales Q/Q5.04%SMA50-35.43%Rel Volume2.91Prev Close2.25
Employees121LT Debt/Eq2.00EarningsFeb 18SMA200-52.02%Avg Volume12.59MPrice2.18
IPO DateJul 07, 2005Option/ShortNo / YesEPS/Sales Surpr.3976.85% -2.63%Net Debt/EBITDA6.41Volume36,651,797Change-3.11%
Analyst Ratings
DateActionAnalystRatingTarget
Oct-30-26DowngradeRBC CapitalSector Perform → Underperform$5.00 → $2.00
Sep-01-26ReiteratedWells FargoUnderweight$5.00 → $3.80
Feb-03-26InitiatedMaximBuy$8.00
Nov-25-25ReiteratedWells FargoUnderweight$7.50 → $5.00
Mar-12-25UpgradeExane BNP ParibasNeutral → Outperform
Mar-11-25ReiteratedBNP Paribas$4.00 → $9.00
Sep-13-24UpgradeColliers SecuritiesNeutral → Buy$6.50
Sep-13-24ReiteratedTruist SecuritiesHold$8.00 → $6.00
Sep-12-24ReiteratedMizuho SecuritiesNeutral$7.00
Aug-02-24ReiteratedWells FargoUnderweight$7.50
Latest News· Times ET
Oct-30-26
Oct-30-2608:15AM
Medical Properties Trust Q3 Earnings Call Highlightsmarketbeat.com
04:15AM
Medical Properties Trust's Collapse Offers A Golden Buying Opportunityseekingalpha.com
Oct-29-26
Oct-29-2605:12PM
Medical Properties Trust, Inc. Reports 2026 Third Quarter Results and Approximately $680 Million in Asset Sale ProceedsFintel
02:48PM
Medical Properties Trust, Inc. (MPT) Q3 2026 Earnings Call Transcriptseekingalpha.com
11:31AM
Medical Properties (MPT) Q3 FFO and Revenues Miss Estimateszacks.com
08:00AM
MPT Reports Third Quarter Resultsbusinesswire.com
Oct-22-26
Oct-22-2601:45PM
A 14.9% Dividend Yield Sounds Great. Western Union Shows Why It Could Be a TrapYahoo
08:00AM
MPT Announces Third Quarter 2026 Financial Results Conference Call and Webcastbusinesswire.com
07:45AM
Are Your Dividends Safe? 4 Payouts the Cash Flow No Longer Covers247wallst.com
Oct-21-26
Oct-21-2606:20PM
Medical Properties Trust: The Market Is Pricing In A Disaster That Isn't Thereseekingalpha.com
Oct-19-26
Oct-19-2603:50PM
Medical Properties Trust has slumped: is it a good dividend stock to buy?invezz.com
08:58AM
Stock Market Today: Nasdaq 100 Rises as AI Chip Rout Reverses, SanDisk Jumps 7%Benzinga
Oct-17-26
Oct-17-2607:15AM
The Biggest Mistakes REIT Investors Make (I Made No. 3)seekingalpha.com
Oct-13-26
Oct-13-2606:34PM
MPT Named to Modern Healthcare’s Best Places to Work 2026 and Newsweek’s America’s Greenest Companies 2027Yahoo
03:23AM
Medical Properties Trust (NYSE:MPT) Hits New 12-Month Low – What’s Next?defenseworld.net
Company

Medical Properties Trust, Inc. functions as a self-managed real estate investment trust (REIT). The company specializes in the financing, acquisition, and construction of healthcare properties, all structured under net-lease agreements. Its extensive property holdings encompass a diverse array of medical establishments, such as rehabilitation centers, extended-stay acute care hospitals, outpatient surgical facilities, hospitals catering to women and children, community and regional general hospitals, medical office complexes, and various other specialized care sites. The trust was established in 2003 by its co-founders, Edward K. Aldag Jr., R. Steven Hamner, Emmett E. McLean, and William Gilliard McKenzie, with its principal offices situated in Birmingham, Alabama.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1,031972996872—————
Cost of Goods Sold Incl. D&A181362742—————
Gross Profit851936968830—————
Selling, General and Administrative Excl. Other121130134146—————
Research and Development
0000—————
Other Operating Expense161266447603—————
Operating Income56854038781—————
Interest Expense553510422411—————
Unusual Expense
—————————
Non-Operating Income (Expense)231-267-2,329-357—————
Net Income Before Taxes246-237-2,364-687—————
Income Taxes-43944-131—————
Consolidated Net Income249-277-2,410-556—————
Net Income From Continuing Operations251-276-2,408-556—————
Net Income249-277-2,410-556—————
EPS (Recurring)0.42-0.46-4.02-0.93—————
EPS (Basic, Before Extraordinaries)0.42-0.46-4.02-0.93—————
EPS (Diluted)0.42-0.46-4.02-0.93—————
EBITDA1,352546-1,488340—————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio
5.19————————
Price To Sales Ratio1.263.092.383.37—————
Gross Margin82.5496.3097.1995.18—————
Operating Margin55.0955.5638.869.29—————
Net Margin24.15-28.50-241.97-63.76—————
Shares Outstanding597601600599—————
Market Capitalization1,3013,0052,3702,941—————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$6.60$5.35$4.10$2.85$1.60● Close Price0.00K74.05K148.09K222.13K296.18KUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Hanna James KevinSenior VP, Controller & CAOAug 20 '26Buy4.152,3009,545542,504Aug 20
Hooper Rosa HandleySVP of OperationsDec 15 '25Sale5.002,00010,000395,182Dec 16
Stewart Michael GDirectorNov 19 '25Sale5.0259,000296,180157,100Nov 21
Stewart Michael GDirectorMay 05 '25Sale5.2029,000150,800216,100May 05
Hanna James KevinSenior VP, Controller & CAOMar 05 '25Buy5.757,41142,613372,338Mar 06
Hanna James KevinSenior VP, Controller & CAODec 26 '24Sale3.7211,64143,305366,913Dec 26
Hooper Rosa HandleySVP of OperationsDec 23 '24Sale3.673,00011,010356,600Dec 26
Stewart Michael GDirectorOct 09 '24Sale5.4632,780178,979221,245Oct 09
Pitman Elizabeth NDirectorSep 18 '24Buy6.018,08748,60376,740Sep 19
THOMPSON C REYNOLDS IIIDirectorAug 27 '24Sale4.3820,53089,92154,637Aug 27
Pitman Elizabeth NDirectorAug 15 '24Sale4.9810,02549,92568,653Aug 15
HAMNER R STEVENExecutive Vice President & CFOApr 07 '22Sale21.04285,0005,996,4001,961,214Apr 08
Aldag Edward K JRChairman, President & CEOMar 30 '22Sale21.33615,00013,117,9503,497,206Apr 01
Stewart Michael GDirectorMar 10 '22Sale20.266,000121,560214,436Mar 10
Stewart Michael GDirectorAug 02 '21Sale20.884,800100,224214,884Aug 03
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.